摘要
心脏植入型电子器械(CIED)包括起搏器、植入型心律转复除颤器(ICD)和心脏再同步化治疗(CRT)等。随着人口老龄化的增加及CIED植入适应证范围的逐渐扩大,CIED植入量逐年增加。但对于临床终末期患者,ICD或CRT联合ICD不但不能延长患者的生存期,反复的电除颤可能会给患者带来严重痛苦。临终患者CIED的管理成为影响终末期患者生存质量的重要问题,现就临终患者CIED的缓和医疗现状和临床管理决策中的影响因素以及临床处理策略展开综述。
Cardiovascular implantable electronic devices(CIED)include pacemaker,implantable cardioverter defibrillator(ICD)and cardiac resynchronization therapy(CRT).With the indications of CIED implantation expanding and the elderly population increasing,the number of CIED implantation is increasingly year by year.But for the end-stage patients,ICD or CRT combined with ICD can not prolong the survival period of patients,and repeated defibrillation may bring severe pain to patients.The management of CIED in terminal patients has become an important issue that affects the quality of life of end-stage patients.Therefore,this article reviews the issue about the palliative care status,the influencing factors in clinical management decision-making and clinical treatment strategies for the end-of-life patients with CIED.
作者
柯万海
戴研
宁晓红
KE Wanhai;DAI Yan;NING Xiaohong(Center of Arrhythmia,Fuwai Hospital,National Center for Cardiovascular Disease,National Key Laboratory of Cardiovascular Disease,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100037,China;Palliative Care Group in Peking Union Medical College Hospital,Peking Union Medical College,Chinese Academy of Medical Sciences,Beijing 100730,China)
出处
《心血管病学进展》
CAS
2020年第5期444-447,共4页
Advances in Cardiovascular Diseases
关键词
心脏植入型电子器械
缓和医疗
管理除颤仪
Cardiovascular implantable electronic devices
Palliative care
Management of implantable cardioverter defibrillator